Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FY8AF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,954
Award facts
- Contract value 100% obligated
- $21,954.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,954.06 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on October 30, 2025, with an ultimate completion date of October 31, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, demonstrates significant capability in federal medical procurement through its extensive portfolio of competitively awarded delivery orders with DLA and other federal agencies. The company serves critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with previous contract awards encompassing diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies. This delivery order for Dupixent, a specialty medication used in immunological treatments, reflects the contractor's role as a key vendor in the federal pharmaceutical supply chain supporting military and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FY8AF?
SPE2DR26FY8AF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DR26FY8AF worth?
The government has obligated $21,954 on SPE2DR26FY8AF.
Is contract SPE2DR26FY8AF an order under another contract?
Yes. SPE2DR26FY8AF is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8AF competed?
The extent of competition for SPE2DR26FY8AF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award